Pharmacokinetics of piperacillin–tazobactam: intermittent dosing versus continuous infusion
- 31 January 2005
- journal article
- clinical trial
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 25 (1) , 62-67
- https://doi.org/10.1016/j.ijantimicag.2004.08.012
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Pharmacodynamic profiling of continuously infused piperacillin/tazobactam against Pseudomonas aeruginosa using Monte Carlo analysisDiagnostic Microbiology and Infectious Disease, 2002
- Beta-Lactam Antibiotics: Is Continuous Infusion The Preferred Method of Administration?Annals of Pharmacotherapy, 1995
- Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infectionsAntimicrobial Agents and Chemotherapy, 1994
- Continuous infusion of beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1992
- Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal ModelThe Journal of Infectious Diseases, 1988
- Therapeutic Efficacy of Continuous Versus Intermittent Administration of Ceftazidime in an Experimental Klebsiella pneumoniae Pneumonia in RatsThe Journal of Infectious Diseases, 1985
- Time course of the pharmacological response to beta-lactam antibiotics in vitro and in vivoEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patientsThe American Journal of Medicine, 1979
- Dosis-Wirkungs-Beziehung der Bakterizidie bei E. coli, K. pneumoniae und Staphylococcus aureusDeutsche Medizinische Wochenschrift (1946), 1976
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976